222 related articles for article (PubMed ID: 15736064)
21. EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.
Okamoto H; Takuwa N; Yatomi Y; Gonda K; Shigematsu H; Takuwa Y
Biochem Biophys Res Commun; 1999 Jun; 260(1):203-8. PubMed ID: 10381367
[TBL] [Abstract][Full Text] [Related]
22. Lysophospholipids--receptor revelations.
Hla T; Lee MJ; Ancellin N; Paik JH; Kluk MJ
Science; 2001 Nov; 294(5548):1875-8. PubMed ID: 11729304
[TBL] [Abstract][Full Text] [Related]
23. Role of lysophosphatidic acid and its receptors in the kidney.
Park F; Miller DD
Physiol Genomics; 2017 Nov; 49(11):659-666. PubMed ID: 28939644
[TBL] [Abstract][Full Text] [Related]
24. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction.
Xu Y
Biochim Biophys Acta; 2002 May; 1582(1-3):81-8. PubMed ID: 12069813
[TBL] [Abstract][Full Text] [Related]
25. Novel bioactive glycerol-based lysophospholipids: new data -- new insight into their function.
Grzelczyk A; Gendaszewska-Darmach E
Biochimie; 2013 Apr; 95(4):667-79. PubMed ID: 23089136
[TBL] [Abstract][Full Text] [Related]
26. 'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies.
Blaho VA; Chun J
Trends Pharmacol Sci; 2018 Nov; 39(11):953-966. PubMed ID: 30343728
[TBL] [Abstract][Full Text] [Related]
27. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
28. Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids.
Goetzl EJ
Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):11-20. PubMed ID: 11324701
[TBL] [Abstract][Full Text] [Related]
29. Lysophospholipid receptor activation of RhoA and lipid signaling pathways.
Xiang SY; Dusaban SS; Brown JH
Biochim Biophys Acta; 2013 Jan; 1831(1):213-22. PubMed ID: 22986288
[TBL] [Abstract][Full Text] [Related]
30. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes.
Noh SJ; Kim MJ; Shim S; Han JK
J Cell Physiol; 1998 Aug; 176(2):412-23. PubMed ID: 9648929
[TBL] [Abstract][Full Text] [Related]
31. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.
Dolezalova H; Shankar G; Huang MC; Bikle DD; Goetzl EJ
J Cell Biochem; 2003 Mar; 88(4):732-43. PubMed ID: 12577307
[TBL] [Abstract][Full Text] [Related]
32. Lysolipids in Vascular Development, Biology, and Disease.
Engelbrecht E; MacRae CA; Hla T
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):564-584. PubMed ID: 33327749
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
Im DS
Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
[TBL] [Abstract][Full Text] [Related]
34. Lysophospholipids in Lung Inflammatory Diseases.
Zhao J; Zhao Y
Adv Exp Med Biol; 2021; 1303():373-391. PubMed ID: 33788203
[TBL] [Abstract][Full Text] [Related]
35. The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells.
Dziak R
Immunol Invest; 2013; 42(7):510-8. PubMed ID: 24004055
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of autotaxin, a lysophosphatidic acid-producing enzyme, enhances cardia bifida induced by hypo-sphingosine-1-phosphate signaling in zebrafish embryo.
Nakanaga K; Hama K; Kano K; Sato T; Yukiura H; Inoue A; Saigusa D; Tokuyama H; Tomioka Y; Nishina H; Kawahara A; Aoki J
J Biochem; 2014 Apr; 155(4):235-41. PubMed ID: 24451492
[TBL] [Abstract][Full Text] [Related]
37. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis.
Pyne NJ; Dubois G; Pyne S
Biochim Biophys Acta; 2013 Jan; 1831(1):228-38. PubMed ID: 22801038
[TBL] [Abstract][Full Text] [Related]
38. Review of the Third Domain Receptor Binding Fragment of Alphafetoprotein (AFP): Plausible Binding of AFP to Lysophospholipid Receptor Targets.
Mizejewski GJ
Curr Drug Targets; 2017; 18(7):874-886. PubMed ID: 26844573
[TBL] [Abstract][Full Text] [Related]
39. Lysophospholipid receptor-mediated calcium signaling in human keratinocytes.
Lichte K; Rossi R; Danneberg K; ter Braak M; Kürschner U; Jakobs KH; Kleuser B; Meyer zu Heringdorf D
J Invest Dermatol; 2008 Jun; 128(6):1487-98. PubMed ID: 18172456
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases.
Takuwa Y; Ikeda H; Okamoto Y; Takuwa N; Yoshioka K
Biochim Biophys Acta; 2013 Jan; 1831(1):185-92. PubMed ID: 22735357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
